Abstract
SCE-963 {7β-[2-(2-aminothiazol-4-yl)acetamido]-3-[({1-(2-dimethylaminoethyl)- 1H-tetrazol-5-yl}thio)methyl]-ceph-3-em-4-carboxylic acid}, a new semisynthetic cephalosporin, showed excellent antibacterial activity against gram-positive and gram-negative bacteria, including Haemophilus influenzae, indole-positive Proteus, Enterobacter species, and Citrobacter freundii. The minimum inhibitory concentrations of SCE-963 against most strains of clinically isolated Escherichia coli, Klebsiella pneumoniae, H. influenzae, and Proteus mirabilis were within the range of 0.2 to 0.78 μg/ml. These activities were about 10 times more potent than those of cefazolin, cephaloridine, and cephalothin. Variations in pH, addition of horse serum, and type of growth medium had no significant effect on the activity of the cephalosporin, but the inoculum size elicited a considerable effect on the activity of β-lactamase-producing strains of bacteria. SCE-963 exerted bactericidal and bacteriolytic effects on Staphylococcus aureus and E. coli. The pronounced in vitro activity was reflected in the remarkable protection in mice infected with a wide range of gram-negative bacteria, such as E. coli, K. pneumoniae, P. mirabilis, Proteus vulgaris, Proteus morganii, and Proteus rettgeri. The protective effects of SCE-963 in mice infected with E. coli, K. pneumoniae, and P. vulgaris varied according to the challenge dose. The activity of SCE-963 was far more potent when the drug was administered parenterally rather than orally.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Comber K. R., Boon R. J., Sutherland R. Comparative effects of amoxycillin and ampicillin on the morphology of Escherichia coli in vivo and correlation with activity. Antimicrob Agents Chemother. 1977 Dec;12(6):736–744. doi: 10.1128/aac.12.6.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hunter P. A., Rolinson G. N., Witting D. A. Comparative activity of amoxycillin and ampicillin in an experimental bacterial infection in mice. Antimicrob Agents Chemother. 1973 Sep;4(3):285–293. doi: 10.1128/aac.4.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kondo M., Tsuchiya K. Comparative in vivo activities of cefsulodin, sulbenicillin, and gentamicin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1978 Jul;14(1):151–153. doi: 10.1128/aac.14.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Callaghan C. H., Sykes R. B., Griffiths A., Thornton J. E. Cefuroxime, a new cephalosporin antibiotic: activity in vitro. Antimicrob Agents Chemother. 1976 Mar;9(3):511–519. doi: 10.1128/aac.9.3.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROLINSON G. N., STEVENS S. Microbiological studies on a new broad-spectrum penicilin, "Penbritin". Br Med J. 1961 Jul 22;2(5246):191–196. doi: 10.1136/bmj.2.5246.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsuchiya K., Kondo M., Nagatomo H. SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother. 1978 Feb;13(2):137–145. doi: 10.1128/aac.13.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tybring L., Melchior N. H. Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro. Antimicrob Agents Chemother. 1975 Sep;8(3):271–276. doi: 10.1128/aac.8.3.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zak O., Vischer W. A., Schenk C., Tosch W., Zimmermann W., Regös J., Suter E. R., Kradolfer F., Gelzer J. CGP 9000: a new orally active, broad-spectrum cephalosporin. J Antibiot (Tokyo) 1976 Jun;29(6):653–655. doi: 10.7164/antibiotics.29.653. [DOI] [PubMed] [Google Scholar]